Cabazitaxel Viatris 60 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung

7680691220012 CH-69122 Konzentrat
Cabazitaxel Viatris 60 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung
Cabazitaxel Viatris 60 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/08/2025
Summary of Product Characteristics
Français
13/08/2025
Summary of Product Characteristics
Italien
13/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1185.0 MG Substance HBESI

Reimbursement information

Public price
CHF 2690.90
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2023

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
69122
Drug name
Cabazitaxel Viatris, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01CD04
Authorization status
Z
Dispensing category
A
First authorization
30/03/2023
Authorization expiration date
29/03/2028
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
CABAZITAXEL Viatris 60 mg/3ml flac 3 ml
Description (DE)
CABAZITAXEL Viatris 60 mg/3ml Durchstf 3 ml
Market launch
30/03/2023
Narcotic (BTM)
No

Original drug

Jevtana, solution à diluer et solvant pour solution pour perfusion
GTIN: 7680615430015
CHF 2942.05
View original